Implementing a blood management protocol during the entire perioperative period allows a reduction in transfusion rate in major orthopedic surgery: a before–after study

Transfusion - Tập 56 Số 3 - Trang 673-681 - 2016
Emmanuel Rineau1, Aurélie Chaudet1, Claire Chassier1, Pascal Bizot2, Sigismond Lasocki1
1Département d’anesthésie réanimation
2Département de Chirurgie Osseuse L'UNAM Université, Université d'Angers, CHU d'Angers Angers France

Tóm tắt

BACKGROUNDPatient blood management (PBM) must be promoted in orthopedic surgery and relies on different strategies implemented during the entire perioperative period. Our aim was to assess whether the introduction of a pre‐, intra‐, and postoperative PBM protocol combining erythropoietin (EPO), ferric carboxymaltose (FCM), and tranexamic acid was effective in reducing perioperative transfusion and postoperative anemia.STUDY DESIGN AND METHODSIn a two‐phase prospective observational study, all patients admitted for total hip or knee arthroplasty were included the day before surgery. In Phase 1, use of EPO, iron, and tranexamic acid was left to the discretion of the anesthesiologists. In Phase 2, a protocol combining these treatments was implemented in the perioperative period. Perioperative hemoglobin levels and transfusion rates were recorded.RESULTSA total of 367 patients were included (184 and 183 in Phase 1 and 2, respectively). During Phase 2, implementing a PBM protocol allowed an increase in preoperative EPO prescription in targeted patients (i.e., with Hb < 13 g/dL; 18 [38%] vs. 34 [62%], p = 0.03) and in postoperative use of intravenous iron (12 [6%] vs. 32 [18%], p = 0.001) and tranexamic acid (157 [86%] vs. 171 [94%] patients, p = 0.02). In Phase 2, the number of patients who received transfusions (24 [13%] vs. 5 [3%], p = 0.0003) and of patients with a Hb level of less than 10 g/dL at discharge (46 [25%] vs. 26 [14%], p = 0.01) were reduced.CONCLUSIONIntroduction of a PBM protocol, using EPO, FCM, and tranexamic acid, reduces the number of perioperative transfusions and of patients with a Hb level of less than 10 g/dL at discharge.

Từ khóa


Tài liệu tham khảo

10.1097/ALN.0b013e3181e08e97

10.1097/EJA.0000000000000202

10.1001/jama.297.22.2481

10.1097/ALN.0b013e31819878d3

10.1016/S0140-6736(11)61381-0

10.1016/S0140-6736(96)04330-9

10.1046/j.1537-2995.2003.00348.x

10.1046/j.1537-2995.1999.39070694.x

10.1111/j.1537-2995.2005.04149.x

10.1213/01.ANE.0000150610.44631.9D

10.1097/ALN.0b013e3182054d06

10.1093/bja/aeq361

10.1097/EJA.0b013e32835f4d5b

10.1093/bja/aes139

10.1016/S0140-6736(13)60808-9

10.1093/bja/aes135

10.1111/trf.12016

10.1155/2013/641876

10.1097/00000542-200611000-00026

10.1136/bmj.e3054

10.1093/bja/aes012

10.1111/trf.12195

10.1093/bja/aen054

10.1016/j.tracli.2008.09.024

10.1056/NEJMoa1012452

Assessing the iron status of populations [Internet]. Geneva: WHO. 2007 [cited 2015 Dec 31]. Available from:http://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/9789241596107.pdf.

10.1093/bja/aeu245

10.1111/j.1537-2995.2009.02518.x

10.1016/S0002-9343(96)00164-7

10.1016/0140-6736(93)91527-S

10.1016/j.arth.2013.01.024

10.1046/j.1537-2995.2001.41070957.x

10.3109/0284186X.2012.702921

10.1053/j.ajkd.2008.05.033

10.1016/S0140-6736(07)60689-8

10.1111/j.1537-2995.2007.01415.x

10.1136/bmj.f4822

10.2165/00003495-200969060-00007

10.1016/S0140-6736(69)91492-5

10.1016/S0140-6736(58)91282-0

10.1007/s00228-003-0599-x

Hyder SM, 2002, Do side‐effects reduce compliance to iron supplementation? A study of daily‐ and weekly‐dose regimens in pregnancy, J Health Popul Nutr, 20, 175

10.1093/bja/aeu092

10.1182/blood-2011-04-346304

10.1186/s13054-014-0542-9

10.1097/EJA.0b013e32834ad97b

10.1093/ajcn/77.2.441

10.1093/ajcn/79.3.437

10.1152/jappl.2000.88.3.1103

10.1056/NEJMoa0908355

10.1093/eurheartj/ehr504

10.1159/000107927

10.1213/ane.0b013e318164f114

10.1186/1472-6963-13-186

Thông tin
Thông tin xuất bản

Transfusion

Tập 56 Số 3

673-681

Thông tin tác giả